DC Chemicals

DCL0023 · Research use only

A1I4R2C18-2 · Instructions for Use

For trained personnel conducting laboratory research.

ProductInformation
Name / catalogA1I4R2C18-2 / DCL0023
FormulaC61H115N7O4
Molecular weight1010.64
Purity specification>95% by ELSD-HPLC

Before preparation

Confirm batch identity, supply format, storage, solvent compatibility and retest date. Read the supplied batch COA and approved SDS. Use appropriate laboratory protection and avoid repeated transfers of small quantities.

Formulation reference

ComponentDC Chemicals productMolecular weightMolar proportionMass contribution per 1 µmol total lipid
A1I4R2C18-2DCL00231010.6450%0.505320 mg
DSPCDC57005790.1510%0.079015 mg
CholesterolDCD-041386.6538.5%0.148860 mg
DMG-PEGNot uniquely mappedNot specified in the patent1.5%Requires the PEG-lipid molecular weight

Example 6 reports a test-lipid:nucleic-acid mass ratio of 11:1. N/P and PEG-lipid molecular weight are not reported. Refer to the source and the Formulation & Performance page for the evidence and limitations.

Stock-solution calculation

Volume (mL) = mass (mg) × 1000 / [1010.64 × concentration (mM)]. This calculation does not establish solubility.

Mass10 mM volume20 mM volume
10 mg0.9895 mL0.4947 mL
25 mg2.4737 mL1.2368 mL
50 mg4.9474 mL2.4737 mL
100 mg9.8947 mL4.9474 mL
250 mg24.7368 mL12.3684 mL

References

  1. Liu Z, Chen Y, He Z, Yue Z. Cationic lipid analog, and composition and use thereof. WO2023142167A1. Applicant: Guangzhou Lide Biomedicine Technology Co Ltd. Published 3 August 2023. Read the original patent. Compound identities: Example 2 and Table 3; formulation: Example 6 (printed page 19); intravenous mouse study: Example 10 (printed page 20), Table 3 (printed page 27). Printed page numbers refer to the supplied publication; PDF pages are two pages higher.